Detalles de la búsqueda
1.
RAS/RAFlandscape in monoclonal plasma cell conditions.
Blood
; 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643494
2.
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
Blood
; 135(5): 360-370, 2020 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31774495
3.
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Biol Blood Marrow Transplant
; 26(12): 2299-2305, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822845
4.
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).
Br J Haematol
; 198(1): 203-206, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35445392
5.
EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas.
Blood
; 135(22): 2004-2009, 2020 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32110798
6.
Prolonged remissions after anti-PD-1 discontinuation in patients with Hodgkin lymphoma.
Blood
; 131(25): 2856-2859, 2018 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29724901
7.
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Am J Hematol
; 89(1): 83-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24108528
8.
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Cancer Chemother Pharmacol
; 2023 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957436
9.
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.
Blood Adv
; 7(19): 5733-5742, 2023 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36477770
10.
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.
Haematologica
; 97(7): 1073-9, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22271893
11.
ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells.
Blood Adv
; 4(20): 5203-5214, 2020 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33095875
12.
Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation.
Eur J Cancer
; 115: 47-56, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31082693
13.
Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies.
Cancer Med
; 7(3): 539-548, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473343
14.
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 58(11): 1179-1181, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558780
15.
Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group.
Lancet Haematol
; 4(1): e46-e55, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28041583
16.
ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells.
Eur J Cancer
; 156 Suppl 1: S23-S24, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649648
17.
Large B-cell lymphomas in adolescents and young adults in comparison to adult patients: a matched-control analysis in 55 patients.
Leuk Lymphoma
; 55(8): 1849-53, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24160849
18.
Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
Leuk Lymphoma
; 55(11): 2508-13, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24506467
19.
Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant.
Leuk Lymphoma
; 57(3): 714-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26750740
20.
Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
Leuk Lymphoma
; 54(2): 417-20, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22702654